Displaying 37 - 48 of 50
Immune-Mediated and Cholestatic Diseases

Final audience questions

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Should we focus on managing QoL?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Debate the issues

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Event summary

Webcasts
View
Immune-Mediated and Cholestatic Diseases

How do we holistically treat patients with PBC?

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Should we focus on monitoring ALP?

Webcasts
View
Metabolism, Alcohol & Toxicity
Wrap-up

Wrap-up

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Agile 3+ and Agile 4: two new scores to better identify advanced fibrosis and cirrhosis in NAFLD patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Clinical cases presentation and discussion

Clinical cases presentation and discussion

Webcasts
View
Metabolism, Alcohol & Toxicity
FAST score for identification of active fibrotic NASH

FAST score for identification of active fibrotic NASH

Webcasts
View